Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Enabling Access to Bariatric and Medical Therapeutic Weight Management Services

NHS Suffolk and North East Essex ICB · compiled

Tender information last checkedLast checked 29 Sept 2026, 21:28.

Opportunity overview

The contract will retain the original services which includes support relating to complex obesity, offering an integrated pathway for weight related medications and surgical treatment options and this will be enhanced with the following. The Services to be included within the Contract Modification are outlined in the Service Specification relating to 'Enabling Access to Medical and Surgical Weight Management Intervention's including the urgent pathway for high BMI patients needing Gynaecological Cancer surgery. The provider will offer both medical and surgical interventions via an integrated pathway, collaborate with other weight management providers within the wider weight management pathway, establishing a weight management single point of access to triage all weight management referrals. The provider has their own ITU in line with NICE requirements for bariatric surgery. The modifications to the contract includes: •additional requirement around establishing an integrated single point of access, •enabling access to NICE approved weight related medication (Tirzepatide) and NHS England delivery models, which will likely incur additional demand (TBD) •repatriation of patients from an out of area provider, who are awaiting tier 3 weight management services and choose to be treated locally •potential modifications relating to phlebotomy arrangements may be included within the scope of the specification and contract. The contract modification will be added to main Acute contract with an annual break clause and will be reviewed annual basis. The specialist obesity service may be subject to change due to elements such as, ITU arrangements and wider NHSE commissioning frameworks relating to weight related medications. National frameworks have indicated a 3-year review point to re-assess delivery options which will include e.g. access to Tirzepatide.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

  • CPV85100000 — Health services

Lots

  • The contract will retain the original services which includes support relating to complex obesity, offering an integrated pathway for weight related medications and surgical treatment options and this will be enhanced with the following. The Services to be included within the Contract Modification are outlined in the Service Specification relating to 'Enabling Access to Medical and Surgical Weight Management Intervention's including the urgent pathway for high BMI patients needing Gynaecological Cancer surgery. The provider will offer both medical and surgical interventions via an integrated pathway, collaborate with other weight management providers within the wider weight management pathway, establishing a weight management single point of access to triage all weight management referrals. The provider has their own ITU in line with NICE requirements for bariatric surgery. The modifications to the contract includes: •additional requirement around establishing an integrated single point of access, •enabling access to NICE approved weight related medication (Tirzepatide) and NHS England delivery models, which will likely incur additional demand (TBD) •repatriation of patients from an out of area provider, who are awaiting tier 3 weight management services and choose to be treated locally •potential modifications relating to phlebotomy arrangements may be included within the scope of the specification and contract. The contract modification will be added to main Acute contract with an annual break clause and will be reviewed annual basis. The specialist obesity service may be subject to change due to elements such as, ITU arrangements and wider NHSE commissioning frameworks relating to weight related medications. National frameworks have indicated a 3-year review point to re-assess delivery options which will include e.g. access to Tirzepatide.Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-04dc11
Main Procurement Category
services

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Id
85100000
Scheme
CPV
Description
Health services

Lots and requirements

Entry 1
Id
1
Description
The contract will retain the original services which includes support relating to complex obesity, offering an integrated pathway for weight related medications and surgical treatment options and this will be enhanced with the following. The Services to be included within the Contract Modification are outlined in the Service Specification relating to 'Enabling Access to Medical and Surgical Weight Management Intervention's including the urgent pathway for high BMI patients needing Gynaecological Cancer surgery. The provider will offer both medical and surgical interventions via an integrated pathway, collaborate with other weight management providers within the wider weight management pathway, establishing a weight management single point of access to triage all weight management referrals. The provider has their own ITU in line with NICE requirements for bariatric surgery. The modifications to the contract includes: •additional requirement around establishing an integrated single point of access, •enabling access to NICE approved weight related medication (Tirzepatide) and NHS England delivery models, which will likely incur additional demand (TBD) •repatriation of patients from an out of area provider, who are awaiting tier 3 weight management services and choose to be treated locally •potential modifications relating to phlebotomy arrangements may be included within the scope of the specification and contract. The contract modification will be added to main Acute contract with an annual break clause and will be reviewed annual basis. The specialist obesity service may be subject to change due to elements such as, ITU arrangements and wider NHSE commissioning frameworks relating to weight related medications. National frameworks have indicated a 3-year review point to re-assess delivery options which will include e.g. access to Tirzepatide.

Contract period

Duration In Days
1,080

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
The service will cover the Suffolk and North East Essex Integrated Care System locality

Delivery locations

Entry 1
Region
UKH14
Entry 2
Region
UKH34

Buyer, suppliers and contacts

Organisation 1
Id
GB-NHS-QJG
Name
NHS Suffolk and North East Essex ICB

Roles

buyer

Address

Region
UKH14
Locality
Ipswich
Postal Code
IP1 2BX
Country Name
United Kingdom
Street Address
Endeavour House, Russell Road

Details

Identifier

Id
QJG
Scheme
GB-NHS
Legal Name
NHS Suffolk and North East Essex ICB

Contact

Name
Jane Garnett
Organisation 2
Id
GB-NHS-RDE
Name
East Suffolk and North Essex NHS Foundation Trust

Roles

supplier

Address

Region
UKH34
Locality
Colchester
Postal Code
CO4 5JL
Country Name
United Kingdom
Street Address
Turner Road

Details

Scale
large

Identifier

Id
RDE
Scheme
GB-NHS
Legal Name
East Suffolk and North Essex NHS Foundation Trust
Organisation 3
Id
GB-FTS-136531
Name
NHS Suffolk and North East Essex Integrated Care Board

Roles

reviewBody

Address

Locality
Ipswich
Postal Code
IP1 2BX
Country Name
United Kingdom
Street Address
Endeavour House, Russell Road

Identifier

Legal Name
NHS Suffolk and North East Essex Integrated Care Board

Contact

Award information

Award 1
Id
003900-2025-06T-ST-22-100183-1
Status
active

Suppliers

Supplier 1
Id
GB-NHS-RDE
Name
East Suffolk and North Essex NHS Foundation Trust

Related lots

1

Contracts and changes

Entry 1
Id
003900-2025-06T-ST-22-100183-1
Status
active
Award ID
003900-2025-06T-ST-22-100183-1
Date Signed
3 Feb 2025, 00:00

Items

Item 1
Id
1
Related Lot
1

Classification

Id
85100000
Scheme
CPV
Description
Health services

Delivery Location

Description
NHS Suffolk and North East Essex Integrated Care Board locality

Delivery locations

Entry 1
Region
UKH14
Entry 2
Region
UKH34

Value

Amount
1,690,482,576
Currency
GBP

Period

Duration In Days
1,080

Amendments

Entry 1
Id
3
Rationale
Need for additional works, services or supplies by the original contractor/concessionaire: The NICE "Obesity: Identification, Assessment and Management" guideline (CG189), highlights the importance of and recommends moving beyond a tiered approach to obesity care. In line with this, SNEE's new integrated weight management and complex obesity disease pathway ensures that patients receive the appropriate support from the right level of service, according to their needs. The provider will offer an integrated service model, collaborating with a range of weight management service providers to deliver both pre- and post-complex obesity care, and leads assessment, clinical prioritisation and triage for the wider weight management pathway. This model also ensures an integrated pathway across medical and surgical interventions. There remains a recognised incidence of serious postoperative complications. Consequently, there is a requirement for critical-care resources for the occasional post-bariatric surgery patient with direct access to an on-site Intensive Treatment Unit (ITU).
Description
The contract will retain the original services which includes support relating to complex obesity, offering an integrated pathway for weight related medications and surgical treatment options and this will be enhanced with the following. The Services to be included within the Contract Modification are outlined in the Service Specification relating to 'Enabling Access to Medical and Surgical Weight Management Intervention's including the urgent pathway for high BMI patients needing Gynaecological Cancer surgery. The provider will offer both medical and surgical interventions via an integrated pathway, collaborate with other weight management providers within the wider weight management pathway, establishing a weight management single point of access to triage all weight management referrals. The provider has their own ITU in line with NICE requirements for bariatric surgery. The modifications to the contract includes: •additional requirement around establishing an integrated single point of access, •enabling access to NICE approved weight related medication (Tirzepatide) and NHS England delivery models, which will likely incur additional demand (TBD) •repatriation of patients from an out of area provider, who are awaiting tier 3 weight management services and choose to be treated locally •potential modifications relating to phlebotomy arrangements may be included within the scope of the specification and contract. The contract modification will be added to main Acute contract with an annual break clause and will be reviewed annual basis. The specialist obesity service may be subject to change due to elements such as, ITU arrangements and wider NHSE commissioning frameworks relating to weight related medications. National frameworks have indicated a 3-year review point to re-assess delivery options which will include e.g. access to Tirzepatide.

Recorded locations

  • Buyer location · Ipswich · UKH14 · IP1 2BX · United Kingdom
  • Delivery location · UKH14
  • Delivery location · UKH34

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04dc11-2025-02-06T09:41:51Zcompiled ·